Theranostics involves the use of specific biomarkers to identify and target cancer cells. These biomarkers are molecules that indicate the presence of cancer and can be targeted by therapeutic agents. The process typically involves imaging techniques such as PET scans or MRI to locate cancer cells, followed by the administration of targeted therapies that directly attack these cells.
